A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 Years in Indonesia (Q98753258)
Jump to navigation
Jump to search
clinical trial
- 16202009080721WXFM0YX
- 669/UN6.KEP/EC/2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 Years in Indonesia |
clinical trial |
|
Statements
A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 Years in Indonesia (English)
0 references
1,620
0 references